Breaking News

You are here » Indian-Commodity  :  Top News  :  Emami reports 49% rise in Q2 consolidated net profit

26-Oct2017

Emami reports 49% rise in Q2 consolidated net profit

Emami has reported results for second quarter ended September 30, 2017.

The company has reported a rise of 17.47% in its net profit at Rs 103.94 crore for the quarter under review as compared to net profit of Rs 88.48 crore for the same quarter in the previous year. Total income of the company increased by 4.17% at Rs 585.10 crore for Q2FY18 as compared Rs 561.70 crore for the corresponding quarter previous year.

On consolidate basis, the company has reported 49.27% rise in its net profit at Rs 98.68 crore for the quarter ended September 30, 2017 as compared to Rs 66.11 crore for the corresponding quarter in the FY17. Total income of the company increased by 6.97% at Rs 633.46 crore for quarter under review as compared to Rs 592.16 crore for the same quarter in the previous year.


Related News

View all news

Crude oil futures end lower on Tuesday

Crude oil futures ended lower on Tuesday with benchmark finishing at its lowest in over a year, as investor attention remained fixed on supply ahead of a key meeting of major oil producers early next month.......

Gold futures end tad lower on Tuesday

Gold futures ended marginally lower on Tuesday, retreating from four-day winning streak, owing to a firmer US currency amid better than expected US housing data. Meanwhile, investors were cautious as they......

Copper futures end lower as world stocks fall

Copper futures ended lower on Tuesday, as world stock markets fell in a tech-led sell-off, while the dollar index rallied from a two-week low, making commodities priced in the greenback more expensive......

Top News

View all news

Megastar Foods planning to incorporate subsidiary

Megastar Foods is planning to incorporate a subsidiary Company. The meeting of the Board of Directors of the company is scheduled to be held on November 27, 2018, to consider the same. Megastar Foods is......

Lupin launches generic Tetrabenazine Tablets

Lupin has launched Tetrabenazine Tablets, 12.5 mg and 25 mg having received an approval from the United States Food and Drug Administration (USFDA) earlier. Lupin's Tetrabenazine Tablets, 12.5 mg and 25......

UPL's arm signs definitive agreement to acquire entire stake of IBC

UPL's wholly owned subsidiary-- UPL Corporation, Mauritius has signed a definitive agreement to acquire directly or through its subsidiaries 100% of the shares of INDUSTRIAS BIOQUIM CENTROAMERICANA, SOCIEDAD......